ISSN: 1538-4047

Journal Home

Journal Guideline

Cancer Biology and Therapy Q2 Unclaimed

Landes Bioscience United States

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Cancer Biology and Therapy is a journal indexed in SJR in Pharmacology and Molecular Medicine with an H index of 120. It has an SJR impact factor of 0.888 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0.888.

Cancer Biology and Therapy focuses its scope in these topics and keywords: cancer, cells, tumor, cell, progression, proliferation, expression, melanoma, pathway, loss, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Cancer Research (Q2) Molecular Medicine (Q2) Oncology (Q2) Pharmacology (Q2)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

0.888

SJR Impact factor

120

H Index

58

Total Docs (Last Year)

448

Total Docs (3 years)

3035

Total Refs

1908

Total Cites (3 years)

443

Citable Docs (3 years)

4.17

Cites/Doc (2 years)

52.33

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Drug Safety - Case Reports Q2
Pharmacoepidemiology and Drug Safety Q2
Clinical Therapeutics Q2
Annals of Pharmacotherapy Q2
Current Cancer Drug Targets Q2

Compare this journals

Aims and Scope

Best articles by citations

Maximizing early detection of esophageal squamous cell carcinoma via SILAC-proteomics

Static magnetic fields impair angiogenesis and growth of solid tumors in vivo

Topotecan as a molecular targeting agent which blocks the Akt and VEGF cascade in platinum-resistant ovarian cancers

Allosteric AKT inhibitors as a targeted cancer therapy

Interleukin-2 gene transfer potentiates the a-galactosylceramide-stimulated antitumor effect by the induction of TRAIL in NKT and NK cells in mouse models of subcutaneous and metastatic carcinoma

In situ photoimmunotherapy: A new hope for cutaneous melanoma patients

Decreased expression of ALDH5A1 predicts prognosis in patients with ovarian cancer

Prostate cancer genomic signature offers prognostic value

Serum metabolite profiling of familial adenomatous polyposis using ultra performance liquid chromatography and tandem mass spectrometry

The C-terminus of interferon gamma receptor beta chain (IFN gammaR2) has antiapoptotic activity as a bax inhibitor

Isolated cardiac peripheral primitive neuroectodermal tumor: A case report

Ethanol Treatment of Hepatocellular Carcinoma: High Potentials of Low Concentrations

SHOW MORE ARTICLES

What accounts for the variable responses to progesterone on Schwann cells from mice and humans - the species-specific influence or the paracrine effects from the tumor microenvironment?

Sunitinib inhibits papillary thyroid carcinoma with RET/PTC rearrangement but not BRAF mutation

RhoBTB2 (DBC2) comes of age as a multifunctional tumor suppressor

Intestinal microorganisms involved in colorectal cancer complicated with dyslipidosis

Minting a new class of Polo-like-kinase inhibitors

A new look at molecular biology of breast cancer

Cyclin E and histone H3 levels are regulated by 5-fluorouracil in a DNA mismatch repair-dependent manner

EpCAM: A New Therapeutic Target for an Old Cancer Antigen

Targeting the checkpoint kinase WEE1: Selective sensitization of cancer cells to DNA-damaging drugs

IL-6 stimulates Th2 type cytokine secretion and upregulates VEGF and NRP-1 expression in pancreatic cancer cells

Capsaicin reactivates hMOF in gastric cancer cells and induces cell growth inhibition

Circulating tumor cells count and characterization in a male breast cancer patient